OpenAI-Backed Chai Discovery Hits $1.3B Valuation

[kevin1]

Chai Discovery, a biotech startup backed by OpenAI, raised $130M in Series B funding, pushing its valuation to $1.3 billion. The round was led by General Catalyst and Oak HC/FT, with participation from Menlo Ventures, Thrive Capital, SV Angel, and others. With total funding now above $225M, Chai is emerging as a major player at the intersection of AI and drug discovery.

[Nahid Hossen]

A $1.3B valuation shows strong belief in AI-first biotech models.